| NCT ID | NCT06939387 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Zhejiang Provincial People's Hospital |
| Condition | Acute Kidney Injury |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,500 participants |
| Start Date | 2025-03-10 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,500 participants in total. It began in 2025-03-10 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To establish the prediction model of renal dysfunction in patients with drug-induced renal injury and study the prognosis of different drug treatments
Eligibility Criteria
Inclusion Criteria: * Drug-induce acute kidney injury Exclusion Criteria: * 1.Dialysis patients; 2.No baseline creatinine; 3.Obstructive AKI; 4.Clinical data were incomplete.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06939387 clinical trial?
This trial is open to participants of all sexes, studying Acute Kidney Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06939387 currently recruiting?
Yes, NCT06939387 is actively recruiting participants. Contact the research team at yexl1120@126.com for enrollment information.
Where is the NCT06939387 trial being conducted?
This trial is being conducted at Hangzhou, China.
Who is sponsoring the NCT06939387 clinical trial?
NCT06939387 is sponsored by Zhejiang Provincial People's Hospital. The trial plans to enroll 1,500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.